Necrotizing leukoencephalopathy following CHOP chemotherapy
University of Minnesota, Department of Medicine, Division of Hematology/Oncology/Transplantation, United States.Leukemia Research (Impact Factor: 2.35). 11/2008; 32(10):1611-4. DOI: 10.1016/j.leukres.2008.02.014
Toxic leukoencephalopathy syndromes are rare disorders of cerebral injury characterized by changes in the white matter and accompanying neurologic dysfunction. They have been reported in association with a variety of clinical etiologies, most commonly including severe hypertension, cranial irradiation, and environmental toxins. However, they have also been described in conjunction with immunosuppressive and chemotherapeutic agents. There has been one case of fatal leukoencephalopathy reported following CHOP chemotherapy for non-Hodgkin lymphoma. We report a second case of fatal necrotizing leukoencephalopathy following the administration of CHOP chemotherapy.
- [Show abstract] [Hide abstract]
ABSTRACT: Patients with hematological malignancies may develop white matter lesions, which are usually associated with chemotherapy. Magnetic resonance imaging (MRI) is the imaging modality of choice for identifying chemotherapy-induced, or "toxic", leukoencephalopathy. Brain biopsy in patients with hematological malignancies suspected of sustaining toxic leukoencephalopathy has rarely been performed, because its characteristic MRI findings are considered pathognomotic. Biopsy may be indicated in atypical cases, however, and it may yield unexpected results. We describe a case with white matter lesions that developed in an elderly man treated for non-Hodgkin's lymphoma. The lesions, initially diagnosed with toxic leukoencephalopathy based on MRI findings, turned out to be gliomatosis cerebri.Internal Medicine 01/2010; 49(7):701-5. DOI:10.2169/internalmedicine.49.2729 · 0.90 Impact Factor
- Journal of medical toxicology: official journal of the American College of Medical Toxicology 04/2010; 6(2):217-29. DOI:10.1007/s13181-010-0053-2
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.